Metraipolis › archive › dc_02af00a1ed62

Dual-Function Adjuvant Cyclosporin A: Enhancing RSV-Specific Humoral Immunity via Treg-Driven B-Cell Activation — Europe PMC PMID:41150386

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41150386
DOI: 10.3390/vaccines13100997
License (as archived): solo-consultazione
Archived: 2026-11-09T19:34:01.556Z
SHA-256 of the archived text: b9b1db4f71958bd4b672ec763d82e12f0dd69cb113585ebd845fda89c61bb93c
Stable URL of this page: https://metraipolis.com/documento/dc_02af00a1ed62

How to cite

Dual-Function Adjuvant Cyclosporin A: Enhancing RSV-Specific Humoral Immunity via Treg-Driven B-Cell Activation — Europe PMC PMID:41150386 — Europe PMC (en), https://europepmc.org/article/MED/41150386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02af00a1ed62 (Metraipolis archive dc_02af00a1ed62, sha256 b9b1db4f71958bd4b672ec763d82e12f0dd69cb113585ebd845fda89c61bb93c)

BibTeX

@misc{dc02af00a1ed62,
  title = {Dual-Function Adjuvant Cyclosporin A: Enhancing RSV-Specific Humoral Immunity via Treg-Driven B-Cell Activation — Europe PMC PMID:41150386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41150386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02af00a1ed62; sha256 b9b1db4f71958bd4b672ec763d82e12f0dd69cb113585ebd845fda89c61bb93c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41150386. Agents can read the archived copy with the MCP tool read_document.